[Side-effects and doping control of anabolic steroids].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Jensen LK;Jensen LK
  • Source:
    Ugeskrift for laeger [Ugeskr Laeger] 1994 Oct 03; Vol. 156 (40), pp. 5872-3.
  • Publication Type:
    Case Reports; English Abstract; Journal Article
  • Language:
    Danish
  • Additional Information
    • Transliterated Title:
      Bivirkninger og dopingkontrol ved brug af anabole steroider.
    • Source:
      Publisher: Den Alm Danske Laegerforening Country of Publication: Denmark NLM ID: 0141730 Publication Model: Print Cited Medium: Print ISSN: 0041-5782 (Print) Linking ISSN: 00415782 NLM ISO Abbreviation: Ugeskr Laeger Subsets: MEDLINE
    • Publication Information:
      Original Publication: Copenhagen : Den Alm Danske Laegerforening
    • Subject Terms:
      Doping in Sports* ; Weight Lifting*; Anabolic Agents/*adverse effects ; Creatine Kinase/*blood; Adult ; Humans ; Male ; Stanozolol/adverse effects ; Trenbolone Acetate/adverse effects
    • Abstract:
      We present a case of a 26 year-old male body-builder who had used the anabolic steroids (AS) trenbolone and stanozolol for 10 weeks. After four weeks creatine-kinase (CK) including CK-B (cardiac specific isoenzymes) levels were elevated five to ten times. He was without cardiac symptoms and electrocardiography was normal. Three weeks after he stopped using AS, CK and CK-B levels had normalized. One of the drugs, stanozolol could not be detected by the doping-control, maybe because of a fast excretion time. Sale, use and delivery of AS is prohibited in Denmark, but is used in spite of the prohibition. It is important to spread knowledge about the risks of AS among the users.
    • Comments:
      Comment in: Ugeskr Laeger. 1994 Nov 28;156(48):7237-8. (PMID: 7817439)
    • Accession Number:
      0 (Anabolic Agents)
      4R1VB9P8V3 (Stanozolol)
      EC 2.7.3.2 (Creatine Kinase)
      RUD5Y4SV0S (Trenbolone Acetate)
    • Publication Date:
      Date Created: 19941003 Date Completed: 19950103 Latest Revision: 20151119
    • Publication Date:
      20231215
    • Accession Number:
      7985283